Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome
? Ovid eligible to receive up to $856M in payments, including a $196M upfront payment, regulatory and commercial milestone payments...

India Left Without Rooms in Dhaka as SAFF Championship Begins with Pakistan Clash
Hero Xpulse 450 Debuts at EICMA 2026 With 421cc Engine and Apple CarPlay
TDP Alliance Breaches Jagan Stronghold to Win Pulivendula Municipality
Yo Yo Honey Singh’s Nephew Divit Auluck Dies in Jalandhar Car Crash
East Bengal host Al Seeb at Salt Lake seeking a first ACL Two win 















